echo "";

Press center

15 July 2016

ExoAtlet, RVC Biofund Portfolio company, invites volunteers with lower paraparesis to pilot medical exoskeletons for rehabilitation as part of clinical studies.

14 July 2016

ExoAtlet, the RVC portfolio company, that manufactures medical exoskeletons for rehabilitation, has obtained the marketing authorization from Federal Service of Surveillance in Healthcare

20 June 2016

Moscow Seed Fund, together with RVC Biofund, have invested 16 million rubles in the "RTM Diagnostics" project.

19 April 2016

Chelyabinsk information technology park is set up with participation of RVC Infrafund and the private investor Maksim Sudakov

3 4 5 6 7  |